EQB Inc. (TSE:EQB) Receives C$122.80 Average Price Target from Analysts
EQB Inc. (TSE:EQB – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the ten analysts that are covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1 year price target among analysts […]
More Stories
iShares Core Dividend Growth ETF (NYSEARCA:DGRO) Shares Sold by Jane Street Group LLC
Jane Street Group LLC reduced its position in iShares Core Dividend Growth ETF (NYSEARCA:DGRO – Free Report) by 95.0% in...
BNP Paribas Financial Markets Makes New $4.58 Million Investment in PROG Holdings, Inc. (NYSE:PRG)
BNP Paribas Financial Markets purchased a new stake in PROG Holdings, Inc. (NYSE:PRG – Free Report) in the 4th quarter,...
BNP Paribas Financial Markets Has $5.32 Million Stock Position in Peabody Energy Co. (NYSE:BTU)
BNP Paribas Financial Markets grew its stake in Peabody Energy Co. (NYSE:BTU – Free Report) by 117.1% in the 4th...
BNP Paribas Financial Markets Sells 26,234 Shares of CubeSmart (NYSE:CUBE)
BNP Paribas Financial Markets lessened its position in CubeSmart (NYSE:CUBE – Free Report) by 16.6% in the fourth quarter, according...
BNP Paribas Financial Markets Has $4.85 Million Stake in LiveRamp Holdings, Inc. (NYSE:RAMP)
BNP Paribas Financial Markets lowered its stake in shares of LiveRamp Holdings, Inc. (NYSE:RAMP – Free Report) by 1.4% during...
BNP Paribas Financial Markets Purchases 70,824 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
BNP Paribas Financial Markets raised its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 491.0% during...